Alpa Laboratories Limited

Sümbol: ALPA.BO

BSE

90.5

INR

Turuhind täna

  • 10.3959

    P/E suhe

  • -0.9674

    PEG suhe

  • 1.90B

    MRK Cap

  • 0.00%

    DIV tootlus

Alpa Laboratories Limited (ALPA-BO) Finantsaruanded

Diagrammil näete Alpa Laboratories Limited (ALPA.BO) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Bilanss

Sukeldudes Alpa Laboratories Limited fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

0808.4702.7424.9
442.7
301.1
178.7
445.1
441.3
721.4
104.6
5.3
1.5
10.4
10.6
12.2

balance-sheet.row.short-term-investments

0720.3687406.9
393
299.6
176.8
421.3
419.4
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0501.4430.8381.4
256.2
315
361.2
409.8
360.4
314
285.1
293.5
321.1
299.6
458.1
502.7

balance-sheet.row.inventory

0126.4154.6165.6
125.5
140.4
137.2
130.4
150
75.2
130
133
155.4
162.7
170.8
226.6

balance-sheet.row.other-current-assets

081.672.7107.8
83.4
37.6
18.1
16.7
16.6
15.7
7.8
5.5
131.3
97.4
6.2
14.3

balance-sheet.row.total-current-assets

01491.21380.11210.9
954.6
940.8
977.2
1046.4
1252.2
1126.3
527.6
437.3
609.3
570
645.7
755.9

balance-sheet.row.property-plant-equipment-net

069.692.287.3
72.3
58.7
61.2
51.8
45.3
48.7
731.1
799.9
682.6
717.2
597.3
535.6

balance-sheet.row.goodwill

0010.6
0
20.2
40.5
60.7
80.9
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

00.810.6
0
0
0
60.7
101.1
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

00.810.6
0
20.2
40.5
60.7
80.9
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

096.561.5104.9
174.9
189.3
129.2
89.8
189.1
107.2
0
0
0
0
0
0

balance-sheet.row.tax-assets

009.30
9.3
1.7
7.6
6.6
6.9
0.9
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

014.58.30
2.4
1.3
-0.4
-0.9
-148.5
107.2
8.4
8.5
8.2
7.6
160.4
295.3

balance-sheet.row.total-non-current-assets

0181.4172.3192.8
258.9
271.2
238
207.9
173.6
156.8
739.5
808.4
690.8
724.8
757.8
830.9

balance-sheet.row.other-assets

0000
0
0.2
0
0.9
0.1
0
0
0
0
0
0
0

balance-sheet.row.total-assets

01672.71552.41403.7
1213.5
1212.2
1215.2
1255.3
1425.9
1283.1
1267.1
1245.7
1300.1
1294.9
1403.5
1586.8

balance-sheet.row.account-payables

0150.6149.2247.3
137
131.9
132.7
139.4
186.6
90.3
106.2
85.2
155.5
184.5
312.4
448.7

balance-sheet.row.short-term-debt

015.337.21.8
2.2
12.6
53.6
102.5
242.3
285.7
160.5
80.4
78.5
94
0
0

balance-sheet.row.tax-payables

022.825.72.9
6.5
0
0
3.1
9.9
0
0
0
0
1.9
1.2
1.1

balance-sheet.row.long-term-debt-total

07.821.20.1
1.9
4.1
6.1
4.7
0
0
42
62
26.7
0
80.8
149.4

Deferred Revenue Non Current

00-25.7-2.2
0
0
0
0
0
0
0
0
0
0
-5.1
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

073.467.438.8
48.6
44.4
30.9
31.5
33.6
36.4
56.3
59.7
51.8
35
41.2
26.1

balance-sheet.row.total-non-current-liabilities

07.821.20.1
1.9
4.2
6.1
145.2
6
5.1
61.1
85.8
36.1
8.3
85.9
156

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0326.9335.1327.3
209.8
227.2
239.8
442.3
503.8
417.5
384
311
321.8
321.9
439.5
630.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0210.4210.4210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4

balance-sheet.row.retained-earnings

0585.8457.3316.4
243.7
224.9
215.5
53
162.1
105.6
123
174.6
218.3
213
203.9
196

balance-sheet.row.accumulated-other-comprehensive-income-loss

0760760760
760
760
759.9
760
760
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0-210.4-210.4-210.4
-210.4
-210.4
-210.3
-210.4
-210.4
549.6
549.6
549.6
549.6
549.6
549.6
549.6

balance-sheet.row.total-stockholders-equity

01345.81217.31076.4
1003.7
984.9
975.5
813
922.1
865.6
883.1
934.6
978.3
973
964
956

balance-sheet.row.total-liabilities-and-stockholders-equity

01672.71552.41403.7
1213.5
1212.2
1215.2
1255.3
1425.9
1283.1
1267.1
1245.7
1300.1
1294.9
1403.5
1586.8

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

01345.81217.31076.4
1003.7
984.9
975.5
813
922.1
865.6
883.1
934.6
978.3
973
964
956

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

077.774.7101.5
172.9
186.3
128.8
47.9
13.1
101
0
0
0
0
90
236.7

balance-sheet.row.total-debt

02358.51.9
4.1
16.7
59.8
107.2
242.3
285.7
202.5
142.4
105.1
94
80.8
149.4

balance-sheet.row.net-debt

0-65.142.7-16.1
-45.6
15.2
57.9
83.4
220.4
-435.7
97.9
137.2
103.6
83.6
70.2
137.1

Rahavoogude aruanne

Alpa Laboratories Limited finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

0156.8195.6107.9
29.1
27.6
46.4
77.5
97.4
-27.1
-49.5
-32.1
8.4
10.8
10.1
0

cash-flows.row.depreciation-and-amortization

013.316.612.3
31.6
31.2
30.7
27.8
8.3
60.7
90.6
47.3
10
11.1
11.7
13

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-814.5-103.4
101.5
-23.9
-163.4
138.5
-284.9
-66.3
14.9
-4.8
-40
31.5
-19.4
5.4

cash-flows.row.account-receivables

0-66.4-0.3-185
97.9
-72.4
12.3
173.7
-121.8
0
0
0
0
0
0
0

cash-flows.row.inventory

028.211-40.1
14.9
-3.2
-6.8
19.6
-74.8
54.9
3
22.4
7.3
8.1
55.8
23.3

cash-flows.row.account-payables

019.8-78.9127.2
-12.1
19
-15.5
-55.2
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

010.382.8-5.5
0.9
32.7
-153.4
0.4
-88.3
-121.2
11.9
-27.2
-47.3
23.3
-75.2
-17.9

cash-flows.row.other-non-cash-items

0-73-127.3-33.8
15.6
-44.9
-40.7
-73.9
-39.4
14.4
24.6
15.2
11.3
-4.4
6.2
2.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-11.3-21.9-32.2
-25.5
-8.5
-19.7
-14.1
-106.1
-11.7
-21.9
-38.9
-26.2
-157.8
-85.3
-33.4

cash-flows.row.acquisitions-net

0-542.33.7
13.7
-57.9
-81.3
77.6
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-0.3-191.87.9
-116.1
-118.7
-98.4
-49.3
-20.6
-101
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

012.315.479.1
13.7
38.7
105.1
3.6
0
461.6
0
0
0
96.7
147
53.5

cash-flows.row.other-investing-activites

025.5-0.10.1
2.5
-0.1
-20.4
42.7
46.4
25.4
0
0.4
-3.9
-149.3
-55.6
-5.9

cash-flows.row.net-cash-used-for-investing-activites

021.3-156.158.6
-111.6
-146.6
-114.7
-17.1
-80.3
374.3
-21.9
-38.5
-9.2
-61.2
61.8
42.8

cash-flows.row.debt-repayment

0-35.4-21.2-1.8
-12.7
-43.3
-49.8
-140.7
-43.4
-42
-20
0
0
0
-68.5
-45.5

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-2.575.63.7
-0.8
-4.5
138.1
-11.6
-12.8
110.2
59.2
17.7
0
0
-3.5
-20.7

cash-flows.row.net-cash-used-provided-by-financing-activities

0-37.954.41.9
-13.5
-47.8
88.3
-152.3
-56.2
68.2
39.2
17.7
12.5
10.2
-72
-66.2

cash-flows.row.effect-of-forex-changes-on-cash

000-0.1
0
0
0.1
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

072.4-2.343.4
52.7
-204.4
-153.3
0.4
-355
424.2
97.9
4.8
-7.1
-2
-1.6
-2.7

cash-flows.row.cash-at-end-of-period

088.115.8105.1
61.7
9
213.5
366.8
172.4
527.4
103.2
5.3
0.5
7.6
9.6
11.2

cash-flows.row.cash-at-beginning-of-period

015.81861.7
9
213.4
366.8
366.4
527.4
103.2
5.3
0.5
7.6
9.6
11.2
13.9

cash-flows.row.operating-cash-flow

08999.4-17
177.8
-10.1
-127
169.9
-218.5
-18.4
80.6
25.6
-10.3
49
8.6
20.7

cash-flows.row.capital-expenditure

0-11.3-21.9-32.2
-25.5
-8.5
-19.7
-14.1
-106.1
-11.7
-21.9
-38.9
-26.2
-157.8
-85.3
-33.4

cash-flows.row.free-cash-flow

077.877.5-49.2
152.4
-18.6
-146.7
155.8
-324.6
-30
58.8
-13.3
-36.5
-108.8
-76.6
-12.7

Kasumiaruande rida

Alpa Laboratories Limited tulud muutusid võrreldes eelmise perioodiga NaN%. ALPA.BO brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

0924.11105.1964.1
848.7
764.2
619
625.4
535.9
573.9
567.1
561.1
551.3
828.7
934.4
1216.8

income-statement-row.row.cost-of-revenue

0615760.9647.6
552.7
530.9
398.1
396.2
307.2
400.1
366.5
403.2
429.8
730.8
843.8
1127.1

income-statement-row.row.gross-profit

0309.1344.3316.6
296.1
233.3
220.9
229.2
228.7
173.8
200.6
157.9
121.5
97.9
90.5
89.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

028.81.50.5
1.1
0.5
0.4
0.1
0.7
1.1
0.1
0.2
0
0.2
0
0

income-statement-row.row.operating-expenses

0235.5248.8219.4
250.8
237.9
199.6
172.6
145.5
192.1
234.5
173.8
105.8
91.5
70.2
78.7

income-statement-row.row.cost-and-expenses

0850.51009.7867
803.5
768.8
597.7
568.8
452.7
592.2
600.9
577
535.6
822.3
914
1205.8

income-statement-row.row.interest-income

010.414.66.5
5.3
29.1
31.8
37.6
40.5
25.6
0.6
0.4
0.3
0.3
0
22.7

income-statement-row.row.interest-expense

00.81.10.3
1
4.8
7.8
16.3
12.8
15
20.9
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

081101.141.7
4.6
28.6
11.4
-19.6
6.6
-34.6
-20.9
-16.3
-7.3
11.2
-8.4
-1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

028.81.50.5
1.1
0.5
0.4
0.1
0.7
1.1
0.1
0.2
0
0.2
0
0

income-statement-row.row.total-operating-expenses

081101.141.7
4.6
28.6
11.4
-19.6
6.6
-34.6
-20.9
-16.3
-7.3
11.2
-8.4
-1

income-statement-row.row.interest-expense

00.81.10.3
1
4.8
7.8
16.3
12.8
15
20.9
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

013.316.612.3
31.6
31.2
30.7
27.8
8.3
60.7
90.6
47.3
10
11.1
11.7
13

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

067.579.669
18.8
-29.7
2.7
38.4
50.2
7.5
-28.6
-15.9
15.7
-0.3
18.5
12.5

income-statement-row.row.income-before-tax

0158.9195.6107.9
29.1
27.6
46.4
56.4
97.4
-27.1
-49.5
-32.1
8.4
10.8
10.1
11.5

income-statement-row.row.income-tax-expense

033.154.735.4
10.5
17.4
18.3
31.2
28.9
-13.1
2
11.6
3.1
1.8
2.2
7.7

income-statement-row.row.net-income

0125.8140.972.5
18.5
10.1
28.1
25.2
68.5
-14
-51.5
-43.7
5.3
9
8
3.8

Korduma kippuv küsimus

Mis on Alpa Laboratories Limited (ALPA.BO) koguvara?

Alpa Laboratories Limited (ALPA.BO) koguvara on 1672699000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.350.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 7.032.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.157.

Mis on ettevõtte kogutulu?

Kogutulu on 0.135.

Mis on Alpa Laboratories Limited (ALPA.BO) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 125828000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 23040000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 235520000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.